{"id":"https://openalex.org/W2576334191","doi":"https://doi.org/10.1182/blood.v118.21.4277.4277","title":"Combination Therapy with Vorinostat and Bortezomib in Patients with High Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes","display_name":"Combination Therapy with Vorinostat and Bortezomib in Patients with High Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes","publication_year":2011,"publication_date":"2011-11-18","ids":{"openalex":"https://openalex.org/W2576334191","doi":"https://doi.org/10.1182/blood.v118.21.4277.4277","mag":"2576334191"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v118.21.4277.4277","doi":"https://doi.org/10.1182/blood.v118.21.4277.4277","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.4277.4277","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061692821","display_name":"Erica Dahl Warlick","orcid":"https://orcid.org/0000-0003-3888-2021","observed_orcids":["https://orcid.org/0000-0003-3888-2021"]},"institutions":[{"id":"https://openalex.org/I4210135252","display_name":"University of Minnesota Medical Center","ror":"https://ror.org/03e1ayz78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1309104334","https://openalex.org/I4210135252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erica D Warlick","raw_affiliation_strings":["Hematology, Oncology, Transplantation, University of Minnesota Medical Center, Minneapolis, MN, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Oncology, Transplantation, University of Minnesota Medical Center, Minneapolis, MN, USA,","institution_ids":["https://openalex.org/I4210135252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008157848","display_name":"Qing Cao","orcid":"https://orcid.org/0000-0002-1523-8797","observed_orcids":["https://orcid.org/0000-0002-1523-8797"]},"institutions":[{"id":"https://openalex.org/I4390039358","display_name":"Masonic Cancer Center","ror":"https://ror.org/05x083d20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I130238516","https://openalex.org/I4390039358"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Qing Cao","raw_affiliation_strings":["Biostatistic Support, Masonic Cancer Center, Minneapolis, MN, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistic Support, Masonic Cancer Center, Minneapolis, MN, USA,","institution_ids":["https://openalex.org/I4390039358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027151969","display_name":"Jeffrey S. Miller","orcid":"https://orcid.org/0000-0002-0339-4944","observed_orcids":["https://orcid.org/0000-0002-0339-4944"]},"institutions":[{"id":"https://openalex.org/I130238516","display_name":"University of Minnesota","ror":"https://ror.org/017zqws13","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey S. Miller","raw_affiliation_strings":["Division of Hematology, Oncology, and Transplant, University of Minnesota, Minneapolis, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Oncology, and Transplant, University of Minnesota, Minneapolis, MN, USA","institution_ids":["https://openalex.org/I130238516"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5008157848"],"corresponding_institution_ids":["https://openalex.org/I4390039358"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.36694114,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"118","issue":"21","first_page":"4277","last_page":"4277"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9570000171661377},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9909999966621399},{"id":"https://openalex.org/keywords/relapsed-refractory-leukemia","display_name":"relapsed/refractory leukemia","score":0.8119999766349792},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.7749999761581421},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.8989999890327454},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.6740000247955322},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/nk-cell-mediated-killing","display_name":"NK cell-mediated killing","score":0.7149999737739563},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.36000001430511475},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.5199999809265137},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.5569999814033508},{"id":"https://openalex.org/keywords/complex-cytogenetics","display_name":"complex cytogenetics","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8511034250259399},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.685238778591156},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.5759103894233704},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.5618799924850464},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5311728119850159},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5016183853149414},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49390727281570435},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.48030680418014526},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45263776183128357},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.43337225914001465},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4229947626590729},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.3238368630409241},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.3168114721775055},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.261709064245224},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1922878623008728},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v118.21.4277.4277","doi":"https://doi.org/10.1182/blood.v118.21.4277.4277","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.4277.4277","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4243030858","https://openalex.org/W1973629152","https://openalex.org/W968810870","https://openalex.org/W2579802222","https://openalex.org/W2141865164","https://openalex.org/W2561700492","https://openalex.org/W2531135360","https://openalex.org/W2561576365","https://openalex.org/W2055926194","https://openalex.org/W4238205969"],"abstract_inverted_index":{"Abstract":[0,1],"4277":[2],"Introduction:":[3],"Patients":[4,54,57,203],"with":[5,36,58,217,270,285,315,381,448,475,491,637],"acute":[6],"myeloid":[7,581],"leukemia":[8],"(AML)":[9],"or":[10,16,70,169,208,288,476,483],"myelodysplastic":[11],"syndromes":[12],"(MDS)":[13],"refractory":[14],"to":[15,27,275,356,365,367,443,471,517,532,536,601,666],"progressive":[17,66,170,271,306],"on":[18,67,657],"standard":[19,264],"therapies":[20],"present":[21],"a":[22,130,205,566,571,633],"challenging":[23],"population":[24],"of":[25,78,97,114,129,185,193,213,222,227,237,243,298,343,362,426,433,440,487,558,568,587,617,627,664],"patients":[26,197,232,253,304,345,354,376,388,396,422,428,435,569,592],"treat":[28],"and":[29,38,47,55,62,88,102,120,127,139,182,245,269,312,370,394,410,431,453,473,525,560,570,593,629],"warrant":[30],"novel":[31],"therapy.":[32,444,488],"Investigational":[33],"combination":[34,557,626],"therapy":[35,135,214,223,299,390,588,595,608,618,636],"vorinostat":[37,115,559,628],"bortezomib":[39,121,561,630],"may":[40,48,631],"synergistically":[41],"target":[42],"additive":[43],"aberrant":[44],"cellular":[45],"processes":[46],"modulate":[49],"NK":[50],"cell":[51],"mediated":[52],"killing.":[53],"Methods:":[56],"refractory/relapsed":[59],"AML":[60,252],"(non-M3)":[61],"high":[63,514],"risk":[64],"MDS":[65,303],"hypomethylating":[68,310],"agents":[69,311],"lenalidomide":[71],"were":[72,108,142,153,198,254,279,313,346,530,540],"eligible.":[73],"Karnofsky":[74],"Performance":[75],"Status":[76],"(KPS)":[77],">":[79,94],"60,":[80],"creatinine":[81],"<":[82,85,90,103],"2,":[83,91,393],"ALT/AST":[84],"3X":[86],"ULN,":[87],"bilirubin":[89],"ejection":[92],"fraction":[93],"40%,":[95],"absence":[96,226],"central":[98],"nervous":[99],"system":[100],"disease,":[101],"grade":[104],"2":[105,387,395],"peripheral":[106],"neuropathy":[107,454],"required":[109,190],"for":[110,191,263,320,348,507,513,640,653],"enrollment.":[111],"Cycles":[112],"consisted":[113],"400":[116],"mg/day":[117],"Day":[118],"1\u201314":[119],"1.3":[122],"mg/m2":[123],"IV":[124],"Days":[125],"1,4,8,":[126],"11":[128],"21":[131],"day":[132],"cycle.":[133],"Pre":[134],"bone":[136],"marrow":[137],"biopsy":[138],"transfusion":[140],"requirements":[141],"documented.":[143],"Disease":[144],"response":[145,274,406],"was":[146,189,300,412,446,522,545,553,613,619],"planned":[147],"after":[148,210,273,308,485,502],"3":[149,211,220,379],"cycles.":[150],"Clinical":[151],"responses":[152],"defined":[154,174],"as":[155,173,542],"complete":[156,357,572],"morphologic":[157,415,573],"remission":[158,161,574],"(CR),":[159],"partial":[160],"(PR),":[162],"hematologic":[163],"improvement":[164],"(HI),":[165],"stable":[166],"disease":[167,171,272,307,326,401,495,563,641],"(SD),":[168],"(PD)":[172],"by":[175,649],"IWG":[176],"criteria.":[177],"(Cheson":[178],"et":[179],"al":[180],"2003":[181],"2006)":[183],"Completion":[184],"1":[186,399],"full":[187,360],"cycle":[188,392,398],"analysis":[192],"clinical":[194,349,405,578],"response.":[195,350],"All":[196,302,425],"included":[199,324,463],"in":[200,224,565,575,580,589,621],"toxicity":[201,543,551,612,644],"assessment.":[202],"achieving":[204],"CR,":[206,416],"PR,":[207,408],"HI":[209],"cycles":[212,221,380,586],"could":[215],"proceed":[216],"an":[218,259],"additional":[219,585],"the":[225,296,321,358,382,434,455,615,622,638],"dose":[228,385,596,655],"limiting":[229],"toxicity.":[230],"Twelve":[231],"(AML=9,":[233],"MDS-3),":[234],"median":[235,241],"age":[236],"66":[238],"(range":[239],"48\u201388),":[240],"KPS":[242],"80,":[244],"predominantly":[246],"male":[247],"(n=7)":[248],"have":[249,533,598],"been":[250,599],"treated.":[251],"primary":[255],"induction":[256,265],"failures":[257],"(n=1),":[258,266,283,331,335],"untreated":[260],"elderly":[261],"unfit":[262],"relapsed/refractory":[267],"(n=3),":[268],"azacitidine":[276],"(n=1).":[277,374],"Cytogenetics":[278],"complex":[280,316],"(n=4),":[281],"7q-":[282],"normal":[284],"FLT3+":[286],"(n=1)":[287,339],"miscellaneous":[289],"abnormalities":[290],"(n=3).":[291],"Median":[292],"blast":[293],"burden":[294],"at":[295],"time":[297],"66%.":[301],"had":[305,423,429],"prior":[309,332,336,493],"RAEB-2":[314],"cytogenetics":[317],"(n=2).":[318],"Comorbidites":[319],"entire":[322],"group":[323],"vascular":[325],"(predominantly":[327],"cardiac":[328,494,499,503],"n=4),":[329],"COPD":[330],"GI":[333],"bleed":[334],"fungal":[337,520],"infection":[338,474,521],"Results:":[340],"A":[341],"total":[342],"9":[344],"evaluable":[347],"The":[351,403,419,549,556,625],"remaining":[352,420],"three":[353],"failed":[355],"first":[359],"round":[361],"chemotherapy":[363],"due":[364],"transition":[366],"hospice":[368],"(n=2)":[369],"unrelated":[371,535],"fall/hip":[372],"fracture":[373],"Five":[375],"completed":[377,389,397],"all":[378],"majority":[383,616],"requiring":[384,436],"reduction,":[386],"through":[391],"before":[400],"progression.":[402],"overall":[404,550],"(CR,":[407],"HI,":[409],"SD)":[411],"56%":[413],"(n=1":[414],"n=4":[417],"SD).":[418],"4":[421],"PD.":[424],"responding":[427,591],"AML,":[430],"none":[432],"initial":[437],"hydroxyurea":[438],"control":[439],"WBC":[441],"responded":[442],"Toxicity":[445,583],"common":[447,457],"fatigue,":[449],"anorexia,":[450],"dehydration,":[451],"nausea,":[452],"most":[456],"side":[458],"effects.":[459],"Severe":[460],"adverse":[461],"effects":[462],"fevers,":[464],"pulmonary":[465,519],"infection,":[466],"QT":[467],"prolongation":[468],"that":[469,544,606],"lead":[470],"syncope,":[472],"without":[477],"neutropenia.":[478],"Two":[479],"deaths":[480],"occurred":[481],"during":[482],"soon":[484],"completion":[486],"One":[489],"patient":[490,511,658],"extensive":[492],"status":[496],"post":[497],"numerous":[498],"stents":[500],"died":[501],"arrest":[504],"when":[505],"admitted":[506],"neutropenic":[508],"fever.":[509],"Another":[510],"hospitalized":[512],"fevers":[515],"related":[516],"possible":[518],"found":[523],"unresponsive":[524],"died.":[526],"While":[527,611],"these":[528],"events":[529],"felt":[531],"causes":[534],"drug":[537],"therapy,":[538],"they":[539],"classified":[541],"possibly":[546],"treatment":[547],"related.":[548],"rate":[552],"50%.":[554],"Conclusion:":[555],"produced":[562],"stability":[564],"subset":[567],"one":[576],"suggesting":[577],"activity":[579],"diseases.":[582],"limited":[584],"some":[590],"protocol":[594],"adjustments":[597],"made":[600],"address":[602],"this":[603],"issue":[604],"so":[605],"extended":[607],"is":[609],"feasible.":[610],"frequent,":[614],"tolerated":[620],"outpatient":[623],"setting.":[624],"be":[632,647],"clinically":[634],"promising":[635],"potential":[639],"stabilization":[642],"if":[643],"issues":[645],"can":[646],"improved":[648],"our":[650],"current":[651],"plan":[652],"tailoring":[654],"based":[656],"tolerance.":[659],"Disclosures:":[660],"No":[661],"relevant":[662],"conflicts":[663],"interest":[665],"declare.":[667]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-01-26T00:00:00"}